How to recognize counterfeit Methenolone acetate

Methenolone acetate is a drug that is rare in legal circulation and expensive, and therefore one of the favorite targets of counterfeiters. The editorial team explains what is really known about the quality of black-market products, why "checking by eye" does not work, and what anti-counterfeit mechanisms exist in the pharmaceutical system.

Why the counterfeit problem is so acute

Methenolone acetate as a registered medicine is today practically unavailable in most countries: pharmaceutical production of oral tablets was long ago reduced, and in many states registration has been discontinued. Demand in the sports community, meanwhile, persists. Such a situation is an ideal environment for counterfeits.

A systematic review and meta-analysis of analytical studies of black-market anabolic steroid products showed that a significant proportion of samples contained a substance other than the one declared, had a different concentration, or contained no active substance at all (Magnolini et al., 2022). Similar results were produced by analyses of products seized at the border in Switzerland (Weber et al., 2017).

For methenolone the situation is further complicated by the fact that it is a relatively expensive substance. Substitution with cheaper steroids, in particular 17α-alkylated ones with higher hepatotoxicity, is economically advantageous for unscrupulous manufacturers.

A counterfeit is not just "it didn't work." It is the risk of getting an unknown substance of unknown dose, contaminated with heavy metals, microorganisms, or solvent residues. A person who thinks they are taking a "mild" drug may in fact be loading the liver far more heavily.

What external signs can and cannot tell you

The internet is full of "instructions" on how to tell the original by the color of the tablet, the font, a hologram, or the taste. The editorial team emphasizes: no visual sign confirms the content of the active substance. Modern equipment allows the packaging to be reproduced very accurately.

An external inspection can only reveal obvious discrepancies that should raise concern: spelling errors, the absence of a batch number and expiration date, mismatches between the blister and the box, a damaged safety seal.

• there is no batch number or manufacturing date, or they are applied unevenly;
• the leaflet is missing or written with errors;
• the manufacturer's name is not found in official registers;
• tablets of different color, size, or with crumbling edges in one package;
• the price is significantly lower than the market price for a registered drug.

However, the reverse is not true: perfect packaging does not guarantee quality. That is precisely why the pharmaceutical industry relies not on "appearance" but on traceability systems.

Evaluating a drug by "feel" is an even less reliable method. Subjective effects strongly depend on expectations, training, and nutrition, and do not allow one to establish which substance and in what amount entered the body.

Official mechanisms of protection against counterfeits

In the European Union, Directive 2011/62/EU on falsified medicines is in force. Under it, prescription drug packaging bears a unique identifier (a 2D code) and an anti-tampering device. Before dispensing, the pharmacy scans the code and verifies it against the European verification system.

In Ukraine the reference point is the State Register of Medicines: in it you can check whether a drug is registered, who the manufacturer is, and what the approved form of release is. A drug that is not in the register cannot legally be sold in a pharmacy.

The key idea is simple: the legal supply chain — a licensed manufacturer, a distributor, a pharmacy, a prescription — is the main protection against counterfeits. All other channels are by definition devoid of quality control.

Laboratory analysis: the only way to know the content

The true composition of a drug can be established only by a laboratory. For steroids, liquid chromatography (HPLC) and gas or liquid chromatography with mass spectrometry are used. These methods identify the substance and determine its quantity, and also detect impurities.

It is precisely by such methods that the control laboratories of regulators and the WADA-accredited anti-doping laboratories work. The studies of seized products that we cite are also based on these technologies.

Home "reagent tests" can give only a crude color reaction to a class of compounds and do not allow one steroid to be distinguished from another with sufficient reliability, let alone establish the dose.

In some countries there are independent substance-checking services that operate within harm-reduction programs. Their results can be useful, but they do not make an illegal product safe: even the correct substance in the correct dose carries all the risks inherent in anabolic steroids.

Consequences of using a counterfeit and when to see a doctor

The consequences of a counterfeit depend on what the product actually contains. Substituting methenolone with a 17α-alkylated steroid increases the risk of cholestasis and toxic liver damage. The presence of estrogenic impurities or aromatizable androgens can cause gynecomastia.

A violation of manufacturing conditions can lead to contamination with heavy metals or microbial contamination. For tablets the latter is less critical than for injections, but it is not entirely excluded.

See a doctor immediately if, after taking any product, jaundice, dark urine, intense abdominal pain, a rash, shortness of breath, chest pain, sudden changes in blood pressure, or changes in mental state appear. It is important to honestly tell the doctor what exactly was taken and, if possible, to keep the packaging.

It is important to understand: the question of quality is not the main risk of anabolic steroids. Even an original drug suppresses the hormonal system, alters lipids, and can affect the psyche. Quality merely adds one more level of uncertainty to this.

Editorial conclusions

Methenolone acetate is one of the most frequently counterfeited substances because of the limited availability of registered forms and its high cost. Studies of illegal products systematically reveal discrepancies between the declared and actual composition.

Visual signs can only raise concern but do not confirm authenticity. Real protection is the legal supply chain, the register of medicines, and serialization systems, while the composition can be reliably determined only by laboratory analysis.

Quality is only one component of the risk. The decision to use any androgen must be made by a doctor for medical indications.

On this topic we also recommend materials on the legal status of methenolone acetate in Ukraine and the EU, on its metabolites, and on the risks of hepatotoxicity of oral steroids.

References

1. Magnolini R, Falcato L, Cremonesi A, et al. Fake anabolic androgenic steroids on the black market — a systematic review and meta-analysis on qualitative and quantitative analytical results found within the literature. BMC Public Health. 2022;22:1371.
2. Weber C, Krug O, Kamber M, Thevis M. Qualitative and semiquantitative analysis of doping products seized at the Swiss border. Subst Use Misuse. 2017;52(6):742–753.
3. Graham MR, Ryan P, Baker JS, et al. Counterfeiting in performance- and image-enhancing drugs. Drug Test Anal. 2009;1(3):135–142.
4. Directive 2011/62/EU of the European Parliament and of the Council of 8 June 2011 amending Directive 2001/83/EC as regards the prevention of the entry into the legal supply chain of falsified medicinal products. Official Journal of the European Union. 2011;L174:74–87.
5. World Anti-Doping Agency. The World Anti-Doping Code: International Standard — Prohibited List. Montreal: WADA; актуальна редакція.
6. Pope HG Jr, Wood RI, Rogol A, et al. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014;35(3):341–375.